F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

The prevalence of “risky behaviour” in adults with cystic fibrosis
Nasal potential difference measurements in diagnosis of cystic fibrosis: An international survey  Lutz Naehrlich, Manfred Ballmann, Jane Davies, Nico.
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
Sweat conductivity: An accurate diagnostic test for cystic fibrosis?
Zachary M. Sellers, Lori McGlocklin, Andrea Brasch 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Scott D. Sagel, Marci K. Sontag, Meg M
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Amoxicillin–clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings  Gwen Duytschaever, Geert Huys,
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis  M. Proesmans, F. Vermeulen,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Delayed publication of clinical trials in cystic fibrosis
Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation  Shahid I. Sheikh, Frederick R. Long, Karen.
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Influence of digital clubbing on oxygen saturation measurements by pulse-oximetry in cystic fibrosis patients  Filip Van Ginderdeuren, Karlien Van Cauwelaert,
Claire Keating, Armeen D
Vitamin A and lung function in CF
Amyloidosis in cystic fibrosis: A case series
A.H. Gifford  Journal of Cystic Fibrosis 
M. Al-Aloul, M. Jackson, G. Bell, M. Ledson, M. Walshaw 
Inhalation solutions — Which ones may be mixed
François Vermeulen, Marijke Proesmans, Mieke Boon, Kris De Boeck 
Elisabeth P. Dellon, Elaine Chen, Jessica Goggin, Karen Homa, Bruce C
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor  Meredith C. Fidler, Jack Beusmans, Paul Panorchan,
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients  E.B. Wilms, D.J. Touw, H.G.M. Heijerman 
Erratum The American Journal of Human Genetics
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Paternity in men with cystic fibrosis: a retrospective survey in France  Ingrid Duguépéroux, Dominique Hubert, Stéphane Dominique, Gil Bellis, Marc De.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
A new method of sweat testing: the CF Quantum®sweat test
C. Van de Kerkhove, P. C. Goeminne, M. Kicinski, T. S. Nawrot, N
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
V. Terlizzi, A. Tosco, R. Tomaiuolo, A. Sepe, N. Amato, A. Casale, C
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Presentation transcript:

Biological variability of the sweat chloride in diagnostic sweat tests: A retrospective analysis  F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal  Journal of Cystic Fibrosis  Volume 16, Issue 1, Pages 30-35 (January 2017) DOI: 10.1016/j.jcf.2016.11.008 Copyright © 2016 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Correlation between the sweat chloride value from the right and the left arm (A); and from the first and second sweat test (B). QNS: Quantity not sufficient. Journal of Cystic Fibrosis 2017 16, 30-35DOI: (10.1016/j.jcf.2016.11.008) Copyright © 2016 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Results of the genetic analysis (retrieved from the files of the patients with two sweat test, of which at least one in the intermediate range), according to the results of the first and of the second sweat test. Journal of Cystic Fibrosis 2017 16, 30-35DOI: (10.1016/j.jcf.2016.11.008) Copyright © 2016 European Cystic Fibrosis Society. Terms and Conditions